Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuregulin-1β Mitigates Doxorubicin-Induced Cardiotoxicity via <i>Serping1</i> in Cardiac Fibroblasts.

International journal of molecular sciences·2026
Same author

Hypoxia-driven microRNA-27b underlies pathologic cardiac endoreplication in heart disease.

Signal transduction and targeted therapy·2026
Same author

Decoding Fibroblast Diversity Associated with the Postnatal Loss of Cardiac Regenerative Capacity.

International journal of molecular sciences·2026
Same author

<i>CLIPPER</i> Regulates LPIN1-Mediated Mitochondrial Biogenesis and Heart Regeneration.

Circulation research·2026
Same author

Circular Tale of Micropeptides in Cardiac Hypertrophy.

Circulation research·2025
Same author

Powering up piRNAs for heart regeneration.

Nature cardiovascular research·2025

Related Experiment Video

Updated: Jun 20, 2026

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Progenitor cell therapy for heart disease.

Christine Gonzales1, Thierry Pedrazzini

  • 1Experimental Cardiology Unit, Department of Medicine, University of Lausanne Medical School, CH-1011 Lausanne, Switzerland.

Experimental Cell Research
|September 15, 2009
PubMed
Summary

Identifying the best progenitor cells for cardiac repair remains challenging. While various cell types show promise, their cardiogenic potential and safety for heart regeneration therapy require further investigation.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Related Experiment Videos

Last Updated: Jun 20, 2026

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells
08:37

Generation of First Heart Field-like Cardiac Progenitors and Ventricular-like Cardiomyocytes from Human Pluripotent Stem Cells

Published on: June 19, 2018

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
10:16

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells
08:00

Derivation of Cardiac Progenitor Cells from Embryonic Stem Cells

Published on: January 12, 2015

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Stem Cell Therapy

Background:

  • Cell transplantation is explored for myocardial repair, but the optimal progenitor cell source is undetermined.
  • Bone marrow and endothelial progenitor cells have shown safety but controversial cardiogenic potential, likely mediating indirect benefits.
  • Human embryonic stem cells offer abundant cardiomyocytes but pose teratoma, ethical, and rejection risks; induced pluripotent stem cells mitigate some issues but retain teratoma risk.

Purpose of the Study:

  • To evaluate various cell types as potential cardiomyocyte sources for cardiac repair.
  • To address the challenges and controversies surrounding the cardiogenic potential and clinical application of different progenitor cells.
  • To explore the identification and isolation of cardiac progenitor cells and alternative regenerative strategies.

Main Methods:

  • Review of current research on cell transplantation therapy for damaged myocardium.
  • Analysis of the potential and limitations of bone marrow-derived cells, endothelial progenitor cells, human embryonic stem cells, induced pluripotent stem cells, and cardiac progenitor cells.
  • Discussion of marker identification, cell stability, electromechanical coupling, and endogenous progenitor mobilization.

Main Results:

  • The cardiogenic potential of bone marrow and endothelial progenitor cells is debated, with observed benefits likely indirect.
  • Human embryonic stem cells and induced pluripotent stem cells offer differentiation potential but carry risks like teratoma formation and graft rejection.
  • Accurate identification and isolation of cardiac progenitor cells remain problematic due to marker overlap with extracardiac progenitors.

Conclusions:

  • No single progenitor cell type is definitively superior for cardiac repair; each has distinct advantages and significant limitations.
  • Further research is needed to refine cell identification, control differentiation, ensure safety, and improve integration for effective cardiac regeneration.
  • Mobilizing endogenous progenitors presents a promising complementary strategy to cell transplantation for promoting cardiac repair.